ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 973,03
-0,43%
Dow Jones
44 303,40
-0,99%
DAX
21 787,00
-0,58%
Brent Oil
74,565
0,00%
Bitcoin
96 668,68
0,21%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Trillium Therapeutics Inc (TRIL)

  7. Trillium Therapeutics Inc (TRIL) Actualités

TRIL

Trillium Therapeutics (TRIL)

Trillium Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TRIL
DateHeureSourceTitreSymboleSociété
22/11/202112h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TRILTrillium Therapeutics Inc
19/11/202121h34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TRILTrillium Therapeutics Inc
19/11/202112h44Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TRILTrillium Therapeutics Inc
17/11/202122h02Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:TRILTrillium Therapeutics Inc
17/11/202122h02Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:TRILTrillium Therapeutics Inc
17/11/202122h01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:TRILTrillium Therapeutics Inc
17/11/202115h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TRILTrillium Therapeutics Inc
17/11/202115h24Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:TRILTrillium Therapeutics Inc
15/11/202123h07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TRILTrillium Therapeutics Inc
12/11/202113h01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TRILTrillium Therapeutics Inc
28/10/202123h00GlobeNewswire Inc.Trillium Therapeutics Receives Final Court Order Approving ArrangementNASDAQ:TRILTrillium Therapeutics Inc
26/10/202123h15GlobeNewswire Inc.Trillium Securityholders Approve Acquisition by PfizerNASDAQ:TRILTrillium Therapeutics Inc
20/10/202112h05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TRILTrillium Therapeutics Inc
27/09/202112h08Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:TRILTrillium Therapeutics Inc
13/09/202122h55Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:TRILTrillium Therapeutics Inc
24/08/202123h14TipRanksPfizer to Purchase Rest of Trillium; Analysts Have Their SayNASDAQ:TRILTrillium Therapeutics Inc
23/08/202112h45GlobeNewswire Inc.Pfizer to Acquire Trillium Therapeutics Inc.NASDAQ:TRILTrillium Therapeutics Inc
13/08/202113h00GlobeNewswire Inc.Trillium Therapeutics Reports Second Quarter 2021 Operating and Financial ResultsNASDAQ:TRILTrillium Therapeutics Inc
09/08/202113h00GlobeNewswire Inc.Trillium Therapeutics Announces Dosing of First Patient in Phase 1b/2 Study of TTI-622 in Combination With Azacitidine in TP53-Mutated Acute Myeloid LeukemiaNASDAQ:TRILTrillium Therapeutics Inc
06/07/202113h00GlobeNewswire Inc.Trillium Therapeutics Announces Dosing of First Patient in Phase 1b/2 Study of TTI-622 in Combination With Azacitidine and Ve...NASDAQ:TRILTrillium Therapeutics Inc
02/07/202122h35Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TRILTrillium Therapeutics Inc
30/06/202113h00GlobeNewswire Inc.Trillium Therapeutics Appoints Catherine Mackey, Ph.D., to Its Board of DirectorsNASDAQ:TRILTrillium Therapeutics Inc
29/06/202113h00GlobeNewswire Inc.Trillium Therapeutics Announces Dosing of First Patient in Phase 1b/2 Study of TTI-621 in Combination With Doxorubicin in Lei...NASDAQ:TRILTrillium Therapeutics Inc
26/06/202100h28GlobeNewswire Inc.Trillium Therapeutics Joins Russell 2000® and 3000® IndicesNASDAQ:TRILTrillium Therapeutics Inc
09/06/202113h00GlobeNewswire Inc.Trillium Announces Voting Results From the Annual General and Special Meeting of ShareholdersNASDAQ:TRILTrillium Therapeutics Inc
07/05/202113h00GlobeNewswire Inc.Trillium Therapeutics Reports First Quarter 2021 Operating and Financial ResultsNASDAQ:TRILTrillium Therapeutics Inc
28/04/202113h01GlobeNewswire Inc.Trillium Therapeutics Announces Dosing of First Patient in Phase 1b Study of TTI-622 in Combination With Carfilzomib and Dex...NASDAQ:TRILTrillium Therapeutics Inc
28/04/202113h00GlobeNewswire Inc.Trillium Therapeutics Provides Data Update, Announces Phase 1b/2 Program Priorities Across Hematologic Malignancies and Solid...NASDAQ:TRILTrillium Therapeutics Inc
22/04/202113h00GlobeNewswire Inc.Trillium Therapeutics to Host Virtual R&D Day for Investors on April 28, 2021NASDAQ:TRILTrillium Therapeutics Inc
18/03/202121h05GlobeNewswire Inc.Trillium Therapeutics Reports Annual Operating and Financial Results and Sets Date for R&D DayNASDAQ:TRILTrillium Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TRIL

Dernières Valeurs Consultées

COIN
XRPUSD
Ripple
SPI
SP500
S&P 500
COIN
AVAXUSD
Avalanche
EU
RI
Pernod Ricard
EU
PX4
SBF 120
NASDAQ
MSFT
Microsoft
COIN
SOLUSD
Solana
NYSE
MRK
Merck
COIN
DOGEUSD
Dogecoin
NYSE
MCD
McDonalds
EU
DG
Vinci
EU
AF
Air FranceKLM
FTSE
UKX
FTSE 100
EU
AI
Air Liquide
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces